Eric Devaney, MD
Pediatric Cardiothoracic Surgery
Accepting New Patients
- Chief, Pediatric Cardiac and Thoracic Surgery, UH Rainbow Babies and Children's Hospital
- Clinical Professor, CWRU School of Medicine
Eric Devaney, MD, is the Chief of Congenital Cardiac Surgery at University Hospitals Rainbow Babies & Children’s Hospital within The Congenital Heart Collaborative. He is also Professor of Surgery at Case Western Reserve University School of Medicine.
Dr. Devaney is board certified in thoracic surgery and congenital heart surgery. His clinical interests and expertise include complex neonatal cardiac surgery and mechanical circulatory support and cardiac transplantation for end-stage heart failure. He was named to the medical staff at UH Rainbow Babies & Children’s Hospital in 2016.
Dr. Devaney earned a bachelor’s degree from University of Virginia, Charlottesville, Va., and his medical degree from University of California, Los Angeles. As a medical student he was inducted into Alpha Omega Alpha Honor Society. He completed general surgical residency at the University of California, San Francisco followed by training in thoracic surgery and a fellowship in pediatric cardiovascular surgery at the University of Michigan in Ann Arbor, Mich. He is a Fellow of the American Association for the Advancement of Science, and other professional memberships include the American Heart Association, the Howard Nafziger Surgical Society, the John Alexander Society, Society of Thoracic Surgeons, Congenital Heart Surgeons Society, the American Association for Thoracic Surgery, and the Western Thoracic Surgical Association.
Dr. Devaney’s clinical research interests include applications of ventricular assist devices in pediatric heart failure and clinical outcomes studies in pediatric cardiac surgery. Dr. Devaney also directs a basic science laboratory which focuses on the molecular mechanisms and therapy of heart failure.
Dr. Devaney has published 58 papers in peer-reviewed medical journals and authored or co-authored seven textbook chapters. From 2007-2014, Dr. Devaney was the lead surgeon on an annual relief mission, through Arturo Grullon Children’s Hospital in Santiago, Dominican Republic and Bloom Hospital in San Salvador, El Salvador. He also serves as an editorial ad hoc reviewer on several major journals including Journal of Thoracic and Cardiovascular Surgery, Annals of Thoracic Surgery, Journal of Pediatrics, Circulation and Pediatric Cardiology.
- Cardiac Transplantation
- Clinical Outcome Studies
- Congenital Heart Disease - Surgery
- Heart Failure
- Neonatal Cardiac Surgery
- Ventricular Assist Devices
- Congenital Cardiac Surgery - American Board of Thoracic Surgery
- Thoracic and Cardiac Surgery - American Board of Thoracic Surgery
Fellowship | Pediatric Cardiovascular Surgery
Pediatric Cardiovascular Surgery - University Of Michigan Medical Center/University Of Michigan Health System (2001 - 2002)
Residency | Thoracic Surgery
Thoracic Surgery - University Of Michigan Medical Center/University Of Michigan Health System (1999 - 2001)
Residency | General Surgery
General Surgery - University Of California San Francisco (USCF) Medical Center At Parnassus (1996 - 1999)
Research Fellowship | Molecular Medicine
Molecular Medicine - University Of California San Francisco (USCF) Medical Center At Parnassus (1993 - 1996)
Residency | General Surgery
General Surgery - University Of California San Francisco (USCF) Medical Center At Parnassus (1991 - 1993)
University Of California, Los Angeles David Geffen School Of Medicine (1991)
University Of Virginia (1984)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Eric Devaney did not disclose any Outside Relationships with Industry.